Enrofloxacin
Product Description
Zhejiang Langhua Pharmaceutical Co., ltd
-
CN -
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
Zhejiang Langhua Pharmaceutical Co., ltd
-
CN
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Zhejiang Langhua Pharmaceutical Co., ltd (4)
-
Product Spironolactone
cardiovascular system drugs CEP and USDMF registered -
Product Levofloxacin Hemihydrate
Quinolones antibacterial product, anti-infective CEP , USDMF registered -
Product Ciprofloxacin Hydrochloride
Wide-range antibacterial -
Product Canrenone
Intermediate grade: Assay: NLT 90%; NLT 97%.
API grade
Zhejiang Langhua Pharmaceutical Co., ltd resources (2)
-
News CPHI Discover: Two-Tier Contract Market in China as Top CDMOs Grab all the Growth
Ahead of CPHI Discover (17-28 May, 2021) - global pharma's largest ever virtual gathering - we spoke to CPHI Annual Report expert Vicky Xia, China Head at BioPlan Associates on the biologics trends she is seeing emerging in the contract services space in China. -
Video Applications of Green Chemistry in API Production
This webinar originally aired as part of CPHI Discover - 17-28 May 2021 Green Chemistry Overview Introduction to Green Chemistry- Twelve Principles and Examples Green Chemistry via Continuous Flow Advantages and Disadvantages Continuous flow reactors Continuous flow chemistry at Langhua
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance